End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.66 MXN | -4.75% | -6.25% | +17.66% |
Sales 2024 * | 17.82B 970M | Sales 2025 * | 19.12B 1.04B | Capitalization | 15.75B 857M |
---|---|---|---|---|---|
Net income 2024 * | 1.98B 108M | Net income 2025 * | 2.22B 121M | EV / Sales 2024 * | 1.08 x |
Net Debt 2024 * | 3.45B 188M | Net Debt 2025 * | 2.83B 154M | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
7.57
x | P/E ratio 2025 * |
7.67
x | Employees | 1,590 |
Yield 2024 * |
-
| Yield 2025 * |
2.01% | Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | -4.75% | ||
1 week | -6.25% | ||
Current month | -6.25% | ||
1 month | -3.25% | ||
3 months | +18.49% | ||
6 months | +21.78% | ||
Current year | +17.66% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Founder | - | 96-10-29 | |
Director/Board Member | - | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 35 M€ | +5.55% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 114 M€ | +4.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 16.66 | -4.75% | 2,739,133 |
24-06-06 | 17.49 | -2.24% | 3,716,123 |
24-06-05 | 17.89 | +3.95% | 2,358,023 |
24-06-04 | 17.21 | +9.41% | 3,041,136 |
24-06-03 | 15.73 | -11.48% | 2,781,943 |
End-of-day quote Mexican S.E., June 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.66% | 860M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- LAB B Stock